Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30058043HIVENSG00000114573.12protein_codingATP6V1ANoNo523P38606
TVIS30058044HIVENSG00000114573.12protein_codingATP6V1ANoNo523P38606
TVIS30058045HIVENSG00000114573.12protein_codingATP6V1ANoNo523P38606
TVIS30058046HIVENSG00000114573.12protein_codingATP6V1ANoNo523P38606
TVIS20036688HPVENSG00000114573.12protein_codingATP6V1ANoNo523P38606
TVIS20056814HPVENSG00000114573.12protein_codingATP6V1ANoNo523P38606
TVIS44006999HTLV-1ENSG00000114573.12protein_codingATP6V1ANoNo523P38606
TVIS44044740HTLV-1ENSG00000114573.12protein_codingATP6V1ANoNo523P38606
TCGA Plot Options
Drug Information
GeneATP6V1A
DrugBank IDDB06733
Drug NameBafilomycin A1
Target IDBE0003569
UniProt IDP38606
Regulation Typeinhibitor
PubMed IDs12689676
CitationsTakami M, Suda K, Sahara T, Itoh K, Nagai K, Sasaki T, Udagawa N, Takahashi N: Involvement of vacuolar H+ -ATPase in incorporation of risedronate into osteoclasts. Bone. 2003 Apr;32(4):341-9.
GroupsExperimental
Direct ClassificationMacrolides and analogues
SMILESCO[C@H]1C=CC=C(C)C[C@H](C)[C@H](O)[C@H](C)C=C(/C)C=C(OC)C(=O)O[C@@H]1[C@@H](C)[C@@H](O)[C@H](C)[C@@]1(O)C[C@@H](O)[C@H](C)[C@H](O1)C(C)C
Pathways
PharmGKB
ChEMBLCHEMBL290814